BACILLUS CALMETTE-GUERIN (BCG) THERAPY IS SAFE AND EFFECTIVE IN NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) PATIENTS WITH IMMUNOSUPPRESSIVE CONDITIONS

被引:0
|
作者
Durant, Adri [1 ]
Choudry, Mouneeb [1 ]
Madura, Grace [1 ]
Mi Lanyu [1 ]
Tyson, Mark [1 ]
Faraj, Kassem [1 ]
机构
[1] Univ Michigan, Mayo Clin Arizona, Ann Arbor, MI 48109 USA
关键词
D O I
10.1016/j.urolonc.2024.01.174
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
136
引用
收藏
页码:S59 / S59
页数:1
相关论文
共 50 条
  • [41] Bacillus Calmette-Guerin (BCG) Treatment Failures in Non-Muscle Invasive Bladder Cancer: What Truly Constitutes Unresponsive Disease
    Steinberg, Ryan L.
    Thomas, Lewis J.
    O'Donnell, Michael A.
    BLADDER CANCER, 2015, 1 (02) : 105 - 116
  • [42] UTILIZATION PATTERNS OF INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR PATIENTS WITH HIGH-GRADE, NON-MUSCLE INVASIVE BLADDER CANCER
    Lenis, Andrew
    Litwin, Mark
    Saigal, Christopher
    Donin, Nicholas
    Lai, Julie
    Hanley, Jan
    Konety, Badrinath
    Chamie, Karim
    JOURNAL OF UROLOGY, 2016, 195 (04): : E8 - E8
  • [43] Bacillus Calmette-Guerin (BCG) unresponsive non-muscle-invasive bladder cancer: are the subgroups equal?
    Tan, Wei Shen
    Grajales, Valentina
    Bree, Kelly
    Li, Roger
    Nogueras-Gonzalez, Graciela M.
    Navai, Neema
    Dinney, Colin
    Kamat, Ashish M.
    BJU INTERNATIONAL, 2023, 132 (04) : 384 - 386
  • [44] Analysis of tolerability of intravesical bacillus Calmette-Guerin (BCG) therapy in non-muscle-invasive bladder cancer.
    Miyazaki, Jun
    Ishizuka, Naoki
    Hinotsu, Shiro
    Akaza, Hideyuki
    Nishiyama, Hiroyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] OUTCOME OF T1 NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) TREATED WITH BACILLUS CALMETTE-GUERIN (BCG): DIFFERENCES BETWEEN PRIMARY AND NON-PRIMARY TUMOURS
    Alkhateeb, S. S.
    Van Rhijn, B. W.
    Bostrom, P. J.
    Hanna, S.
    Vajpeyi, R.
    Finelli, A.
    Fleshner, N. E.
    Jewett, M. A. S.
    Zlotta, A. R.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 92 - 93
  • [46] A phase 3, single-arm study of CG0070 in subjects with non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).
    Uchio, Ed
    Lamm, Donald
    Shore, Neil
    Bivalacqua, Trinity
    Kamat, Ashish
    Tyson, Mark
    Anderson, Paul
    Grandi, Paola
    Burke, James
    CANCER RESEARCH, 2022, 82 (12)
  • [47] LACTOCOCCUS LACTIS SECRETING ATTENUATED RECOMBINANT STAPHYLOCOCCAL ENTEROTOXIN B (RSEB) EXCEEDS BACILLUS CALMETTE-GUERIN (BCG) IN THE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Reis, Leonardo
    Castilho, Mariana
    Mobilon, Cristiane
    da Silveira, Wanderley
    Azevedo, Vasco
    Favaro, Wagner
    JOURNAL OF UROLOGY, 2013, 189 (04): : E217 - E218
  • [48] A Phase 3, Single-Arm Study of CG0070 in Subjects with Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)
    Uchio, Edward
    Lamm, Donald
    Anderson, Paul D.
    Tran, Ben
    Kamat, Ashish
    McAdory, John
    Keel, Melody
    Grandi, Paola
    Burke, James
    MOLECULAR THERAPY, 2021, 29 (04) : 320 - 320
  • [49] A PHASE 3, SINGLE-ARM STUDY OF CG0070 IN SUBJECTS WITH NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Uchio, Ed
    Lamm, Donald
    Shore, Neal
    Anderson, Paul
    Ben, Tran
    Kamat, Ashish
    McAdory, John
    Keel, Melody
    Grandi, Paola
    Burke, James
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A456 - A456
  • [50] Urinary cytokine profiles reflect rationale for treatment with gemcitabine and Bacillus Calmette-Guerin (BCG) in BCG-exposed high-risk non-muscle invasive bladder cancer (NMIBC)
    Gaffney, Christopher D.
    Alam, Syed M.
    Lavery, Jessica A.
    Basar, Merve
    D'Souza, Neeta
    Hernandez, Christian
    McCarter, Melissa
    Moran, Patricia
    Stasi, Kristen
    Worth, Kara
    Sjoberg, Daniel
    Dalbagni, Guido
    Donahue, Timothy
    Donat, Sherri
    Bajorin, Dean
    Bochner, Bernard H.
    Goh, Alvin
    Sarungbam, Judy
    Al-Ahmadie, Hikmat
    Pietzak, Eugene J.
    CLINICAL CANCER RESEARCH, 2024, 30 (10)